Valsartan, Losartan, & Irbesartan Causing Cancer
Written By: Rheingold Giuffra Ruffo & Plotkin LLP
Drug Liability Attorneys in New York City
In July of 2018, the FDA has announced that the blood pressure medications known as Valsartan, Losartan, and Irbesartan have been recalled due to the carcinogen N-Nitrosodimethylamine (NDMA) was found present in the product. In recent litigation it has been established that the foreign manufacturers of the Active Pharmaceutical Ingredients (API), failed to disclose every ingredient and side effects. The manufacturers have fraudulently concealed information from the FDA for this drug to be passed. Many of our clients have gotten recall letters from their pharmacies, and we maintain a current list for all recalls. At Rheingold Giuffra Ruffo & Plotkin LLP, our New York defective drug lawyers handle cases directly and do not refer them to other firms.
More blood pressure medication recalled: Company recalls 80 lots of valsartan over cancer concerns
The company known as Torrent Pharmaceuticals has recalled two of their blood pressure medications known as valsartan and losartan, due to the discovery of an impurity found within the ingredients. The ingredients found has above the acceptable levels of NDMA, prescribed by the FDA. This recall comes with a string of other medications related to valsartan, this recall also includes many other big pharmaceutical companies overseas. This recalled impurity is related to the medications made in Indian and Chinese factories due to the API that is contaminated in their manufacturing sites. Other manufactures include foreign companies such as, Aurobindo Pharma Ltd., Hetero Drugs Ltd., and Mylan Laboratories.
Cancers from taking valsartan, losartan and irbesartan can include:
- Liver cancer
- Stomach cancer
- Pancreatic cancer
- Kidney cancer
- Colorectal cancer
- Esophageal cancer
- Small Intestine cancer
Our litigation partners personally work with clients to determine the extent of the monetary damage this drug has caused them, and what legal remedies are at their disposal.
FIRM EXPERIENCED IN DEALING WITH PHARMACEUTICAL COMPANIES
Our New York dangerous drug lawyers perform a rigorous investigation of the impact this injury has had on clients and their families, both medically and financially. We have access to expert witnesses in pharmacology and other relevant fields who help us determine how dangerous drugs contributed to your injuries and who is liable for the damages. We offer every client personal, individual and attentive client service and dedication to results. Furthermore through our extensive litigation against Japanese pharmaceutical companies, we are experienced with lawsuits involving dangerous drugs, and foreign pharmaceutical.
Our New York defective drug attorneys are able to handle a wide range of drug liability claims, including those involving the prescription drug Valsartan. Call (888) 260-0473 for a free case evaluation.